Cargando…
Rationally designed approaches to augment CAR-T therapy for solid tumor treatment
Chimeric antigen receptor T cell denoted as CAR-T therapy has realized incredible therapeutic advancements for B cell malignancy treatment. However, its therapeutic validity has yet to be successfully achieved in solid tumors. Different from hematological cancers, solid tumors are characterized by d...
Autores principales: | Zhu, Chaojie, Wu, Qing, Sheng, Tao, Shi, Jiaqi, Shen, Xinyuan, Yu, Jicheng, Du, Yang, Sun, Jie, Liang, Tingxizi, He, Kaixin, Ding, Yuan, Li, Hongjun, Gu, Zhen, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696433/ http://dx.doi.org/10.1016/j.bioactmat.2023.11.002 |
Ejemplares similares
-
Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy
por: Li, Hongjun, et al.
Publicado: (2021) -
Rational design of a topological polymeric solid electrolyte for high-performance all-solid-state alkali metal batteries
por: Su, Yun, et al.
Publicado: (2022) -
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy
por: Lorenzini, Theo, et al.
Publicado: (2023) -
The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018) -
New Strategies for the Treatment of Solid Tumors with CAR-T Cells
por: Zhang, Hao, et al.
Publicado: (2016)